hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06383195, orgStudyIdInfo id: SBA 24/189, briefTitle: The Reliability and Validity of the Ankylosing Spondylitis Performance Index (ASPI) in Enthesitis-Related Arthritis, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03-21, primaryCompletionDateStruct date: 2026-03-20, completionDateStruct date: 2026-03-20, studyFirstPostDateStruct date: 2024-04-25, lastUpdatePostDateStruct date: 2024-04-25, sponsorCollaboratorsModule leadSponsor name: Hacettepe University, class: OTHER, descriptionModule briefSummary: This study assesses the test-retest reliability, construct validity, and minimal detectable change of the Ankylosing Spondylitis Performance Index (ASPI) in assessing the physical function of patients with Enthesitis-related arthritis (ERA)., conditionsModule conditions: Enthesitis Related Arthritis, conditions: Enthesitis Related Arthritis, Juvenile, designModule studyType: OBSERVATIONAL, designInfo observationalModel: OTHER, timePerspective: CROSS_SECTIONAL, enrollmentInfo count: 40, type: ESTIMATED, outcomesModule primaryOutcomes measure: Ankylosing Spondylitis Performance Index (ASPI), secondaryOutcomes measure: Childhood Health Assessment Questionnaire (CHAQ), secondaryOutcomes measure: Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), secondaryOutcomes measure: Bath Ankylosing Spondylitis Functional Index (BASFI), secondaryOutcomes measure: Bath Ankylosing Spondylitis Metrology Index (BASMI), secondaryOutcomes measure: Modified Paediatric Mini Mental Scale (MPMMS), eligibilityModule sex: ALL, minimumAge: 7 Years, maximumAge: 18 Years, stdAges: CHILD, stdAges: ADULT, contactsLocationsModule locations facility: Hacettepe University, status: RECRUITING, city: Ankara, country: Turkey, contacts name: Sinan Buran, RA, role: CONTACT, email: pt.sinanburan@gmail.com, geoPoint lat: 39.91987, lon: 32.85427, hasResults: False
protocolSection identificationModule nctId: NCT06383182, orgStudyIdInfo id: Y (2024) 054, briefTitle: Change in Serum Biomarkers After Endovascular Treatment for Acute Anterior Circulation Large Vessel Occlusion, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-05-07, primaryCompletionDateStruct date: 2026-12-30, completionDateStruct date: 2026-12-30, studyFirstPostDateStruct date: 2024-04-25, lastUpdatePostDateStruct date: 2024-04-25, sponsorCollaboratorsModule leadSponsor name: General Hospital of Shenyang Military Region, class: OTHER, descriptionModule briefSummary: Acute ischaemic stroke (AIS) results in high rates of neurological morbidity and mortality, especially in patients with large vessel occlusion (LVO). Endovascular therapy (EVT) has been approved as the most effective treatment for patients with LVO, but about half patients undergoing EVT did not achieve good outcome. The mechanisms of poor prognosis are complex. How to accurately identify serological biomarkers related to patients' clinical prognosis is an important research topic nowadays., conditionsModule conditions: Ischemic Stroke, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 200, type: ESTIMATED, armsInterventionsModule interventions name: endovascular treatment, outcomesModule primaryOutcomes measure: Dynamic changes in serum biomarkers after endovascular treatment, secondaryOutcomes measure: favourable functional outcome, defined as modified Rankin Scale (mRS) 0-2, secondaryOutcomes measure: excellent functional outcome, defined as modified Rankin Scale (mRS) 0-1, secondaryOutcomes measure: distribution of modified Rankin Scale (mRS) score, secondaryOutcomes measure: early neurological improvement, defined as 4 or more decrease in National Institute of Health stroke scale (NIHSS), secondaryOutcomes measure: changes in National Institute of Health stroke scale (NIHSS), secondaryOutcomes measure: symptomatic intracranial hemorrhage (sICH), secondaryOutcomes measure: occurence of new stroke or other vascular events, otherOutcomes measure: the association between cerebral circulation time (CCT) and clinical outcomes, otherOutcomes measure: the association between serum biomarkers and clinical outcomes, otherOutcomes measure: the association between serum biomarkers and status of vessel recanalization, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 80 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: General Hospital of Northern Theater Command, city: ShenYang, zip: 110840, country: China, geoPoint lat: 41.79222, lon: 123.43278, hasResults: False
protocolSection identificationModule nctId: NCT06383169, orgStudyIdInfo id: wanglizhong, briefTitle: Impact of External Drainage of the Lumbar Cistern in Patients With Hydrocephalus Following Meningioma Surgery and Its Influence on Patient Satisfaction, statusModule overallStatus: COMPLETED, startDateStruct date: 2019-05-01, primaryCompletionDateStruct date: 2022-05-01, completionDateStruct date: 2022-05-30, studyFirstPostDateStruct date: 2024-04-25, lastUpdatePostDateStruct date: 2024-04-25, sponsorCollaboratorsModule leadSponsor name: First Hospital of Zhangjiakou City, class: OTHER, descriptionModule briefSummary: This study aims to investigate the effect of external lumbar cistern drainage in preventing postoperative hydrocephalus in patients who have undergone meningioma surgery and its impact on patient satisfaction., conditionsModule conditions: Investigate the Effect of External Lumbar Cistern Drainage in Preventing Postoperative Hydrocephalus in Patients Who Have Undergone Meningioma Surgery, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: RETROSPECTIVE, enrollmentInfo count: 86, type: ACTUAL, armsInterventionsModule, outcomesModule primaryOutcomes measure: Comparison of general clinical data, primaryOutcomes measure: Comparison of the response rate, primaryOutcomes measure: Comparison of GCS scores and intracranial pressure, primaryOutcomes measure: Comparison of KPS scores and satisfaction, eligibilityModule sex: ALL, stdAges: CHILD, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: First Hospital of Zhangjiakou City, city: Zhangjiakou, country: China, geoPoint lat: 40.81, lon: 114.87944, hasResults: False
protocolSection identificationModule nctId: NCT06383156, orgStudyIdInfo id: MD157/2023, briefTitle: The Use of Lung US, Fluoroscopy and Auscultation to Confirm Proper Positioning of Left Sided DLT : A Comparative Study, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-17, primaryCompletionDateStruct date: 2024-09-18, completionDateStruct date: 2024-10-01, studyFirstPostDateStruct date: 2024-04-25, lastUpdatePostDateStruct date: 2024-04-25, sponsorCollaboratorsModule leadSponsor name: Ain Shams University, class: OTHER, descriptionModule briefSummary: The aim of this study is to compare between The Use of Lung ultrasound, Fluoroscopy and Auscultation to Confirm Proper Positioning of Left Sided DLT in elective thoracic surgeries., conditionsModule conditions: Endotracheal Tube Wrongly Placed During Anesthetic Procedure, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, whoMasked: PARTICIPANT, enrollmentInfo count: 90, type: ESTIMATED, armsInterventionsModule interventions name: Double lumen endotracheal tube, outcomesModule primaryOutcomes measure: the specificity in confirming the position of the LDLT and matching the observation of flexible bronchoscope, secondaryOutcomes measure: sensitivity and accuracy in confirming the position of the LDLT., eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 60 Years, stdAges: ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06383104, orgStudyIdInfo id: MyoLupus, briefTitle: Myofascial Techniques and Proprioceptive Neuromuscular Facilitation in Patients With Systemic Lupus Erythematosus., statusModule overallStatus: RECRUITING, startDateStruct date: 2024-04-22, primaryCompletionDateStruct date: 2024-05-28, completionDateStruct date: 2024-06-26, studyFirstPostDateStruct date: 2024-04-25, lastUpdatePostDateStruct date: 2024-04-25, sponsorCollaboratorsModule leadSponsor name: Universidad Católica San Antonio de Murcia, class: OTHER, descriptionModule briefSummary: Introduction. Systemic lupus erythematosus is an autoimmune disease. The musculoskeletal system is affected in 90% of patients. The most common manifestations are myalgias, arthralgias and arthritis.Objective. To analyse the efficacy of an intervention using myofascial techniques and proprioceptive neuromuscular facilitation in patients with systemic lupus erythematosus.Methods. Randomised clinical study with 20 patients with systemic lupus erythematosus, randomised to an experimental and control group. The intervention will last 4 weeks, with a periodicity of 2 weekly sessions of 50 minutes each. The intervention of the experimental group will consist of a protocol using myofascial and proprioceptive neuromuscular facilitation techniques.Expected results. Improvement of knee and ankle pain intensity, functional capacity, basic mobility skills, strength, balance, agility and fatigue., conditionsModule conditions: System; Lupus Erythematosus, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: CROSSOVER, primaryPurpose: PREVENTION, maskingInfo masking: SINGLE, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 20, type: ESTIMATED, armsInterventionsModule interventions name: Intervention, outcomesModule primaryOutcomes measure: Change from baseline joint pain after treatment and at 4 weeks, secondaryOutcomes measure: Change from baseline functional capacity after treatment and at 4 weeks, secondaryOutcomes measure: Change from baseline functionality after treatment and at 4 weeks, secondaryOutcomes measure: Change from baseline joint pain after treatment and at 4 weeks, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 55 Years, stdAges: ADULT, contactsLocationsModule locations facility: Universidad Católica San Antonio, Murcia, status: RECRUITING, city: Murcia, zip: 30107, country: Spain, contacts name: RUBEN CUESTA-BARRIUSO, PhD, role: CONTACT, phone: +34 968278545, email: rcuesta@ucam.edu, geoPoint lat: 37.98704, lon: -1.13004, hasResults: False
protocolSection identificationModule nctId: NCT06383078, orgStudyIdInfo id: MA-PC-II-012, briefTitle: HR070803 in Combination With Oxaliplatin, S-1 Versus NALIRIFOX as Adjuvant Therapy for Pancreatic Cancer, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-20, primaryCompletionDateStruct date: 2027-03-01, completionDateStruct date: 2027-12-30, studyFirstPostDateStruct date: 2024-04-25, lastUpdatePostDateStruct date: 2024-04-25, sponsorCollaboratorsModule leadSponsor name: The First Affiliated Hospital with Nanjing Medical University, class: OTHER, descriptionModule briefSummary: The purpose of this study is to evaluate the efficacy and safety of HR070803 in Combination With Oxaliplatin plus Tegafur compared to HR070803 in combination with oxaliplatin, 5-fluorouracil/leucovorin (5FU/LV) treatment as adjuvant therapy in patients with resected pancreatic cancer., conditionsModule conditions: Efficacy and Safety, designModule studyType: INTERVENTIONAL, phases: PHASE2, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 120, type: ESTIMATED, armsInterventionsModule interventions name: HR070803, interventions name: Oxaliplatin, interventions name: Tegafur, interventions name: Folinic acid, interventions name: 5-Fluorouracil, outcomesModule primaryOutcomes measure: 1-year Disease-free survival rate, secondaryOutcomes measure: Overall survival (OS), secondaryOutcomes measure: Disease-free survival（DFS）, eligibilityModule sex: ALL, minimumAge: 20 Years, maximumAge: 75 Years, stdAges: ADULT, stdAges: OLDER_ADULT, hasResults: False
protocolSection identificationModule nctId: NCT06383065, orgStudyIdInfo id: YDU/2020/76-1007, briefTitle: Respiratory Physiotherapy in Type 2 Diabetes and Bariatric Surgery, statusModule overallStatus: COMPLETED, startDateStruct date: 2020-02-01, primaryCompletionDateStruct date: 2021-04-30, completionDateStruct date: 2022-01-30, studyFirstPostDateStruct date: 2024-04-25, lastUpdatePostDateStruct date: 2024-04-25, sponsorCollaboratorsModule leadSponsor name: Near East University, Turkey, class: OTHER, descriptionModule briefSummary: The aim of this study is to investigate the early effects of Inspiratory Muscle Training (IMT) applied before and after bariatric surgery on respiratory function, respiratory muscle strength and functional capacity in individuals with type 2 diabetes.The study will be conducted with 40 individuals with type 2 diabetes aged between 25-65. Individuals will be randomly assigned to the IMT (trained at 30% of maximum inspiratory pressure with an IMT threshold device) and control group. As measurement parameters, a 6-minute walk test for functional capacity, a spirometry test for respiratory function, and a portable device (Cosmed Pony FX Desktop Spirometer, USA) will be used for respiratory muscle strength. Hand grip strength will be measured with a Baseline dynamometer. All measurements will be repeated on the first day before surgery and on the fourth day before discharge after surgery., conditionsModule conditions: Type 2 Diabetes, conditions: Bariatric Surgery Candidate, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 40, type: ACTUAL, armsInterventionsModule interventions name: IMT Group, outcomesModule primaryOutcomes measure: Respiratory Muscle Strength, primaryOutcomes measure: Respiratory Function, primaryOutcomes measure: Functional Capacity: The 6-minute walk test, primaryOutcomes measure: Hand Grip Strength, eligibilityModule sex: ALL, minimumAge: 25 Years, maximumAge: 65 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Near East University, city: Nicosia, country: Cyprus, geoPoint lat: 35.17531, lon: 33.3642, hasResults: False
protocolSection identificationModule nctId: NCT06383052, orgStudyIdInfo id: NYM032Z01, briefTitle: A Phase 1/2 Study of 177Lu-NYM032 Injection in mCRPC, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-04-30, primaryCompletionDateStruct date: 2024-11-30, completionDateStruct date: 2024-11-30, studyFirstPostDateStruct date: 2024-04-25, lastUpdatePostDateStruct date: 2024-04-25, sponsorCollaboratorsModule leadSponsor name: Norroy Bioscience Co., LTD, class: INDUSTRY, descriptionModule briefSummary: 177Lu-NYM032 injection is a radioligand therapeutic agent that targets prostate specific membrane antigen (PSMA)-expressing prostate tumors. NYM032 is a small molecular with strong affinity for PSMA., conditionsModule conditions: Metastatic Castration-resistant Prostate Cancer, designModule studyType: INTERVENTIONAL, phases: PHASE1, phases: PHASE2, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 24, type: ESTIMATED, armsInterventionsModule interventions name: 177Lu-NYM032 injection, outcomesModule primaryOutcomes measure: Number of Patients With Dose Limiting Toxicity (DLT), primaryOutcomes measure: Maximum Tolerated Dose (MTD), eligibilityModule sex: MALE, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Affliated Hospital of Jiangnan University, status: RECRUITING, city: Wuxi, zip: 214000, country: China, contacts name: Chunjing Yu, role: CONTACT, phone: 15312238622, email: ycj_wxd1978@163.com, geoPoint lat: 31.56887, lon: 120.28857, hasResults: False
protocolSection identificationModule nctId: NCT06383039, orgStudyIdInfo id: ZSoy, briefTitle: Transcranial Direct Current Stimulation and Balance, acronym: tDCS, statusModule overallStatus: COMPLETED, startDateStruct date: 2022-05-16, primaryCompletionDateStruct date: 2022-09-06, completionDateStruct date: 2023-05-13, studyFirstPostDateStruct date: 2024-04-25, lastUpdatePostDateStruct date: 2024-04-25, sponsorCollaboratorsModule leadSponsor name: Zeynep Soy, class: OTHER, descriptionModule briefSummary: Postural control is an adaptive sensorimotor process involving continuous integration of sensory information from three channels. These; visual, somatosensory (proprioceptive) and vestibular senses. The study will be carried out at Istanbul Medipol University. 30 healthy individuals between the ages of 18-25 will be included. To each individual Anodal-supplementary motor area tDCS, Anodal-cerebellar tDCS, Sham tDCS applications will be cross-applied. tDCS application will take 20 minutes and each individual will receive 3 sessions in total. There will be a 72-hour rest period between sessions. Individuals assessed with Demographic Information Form for demographic information, Wii-Fit and Balance Error Scoring System for Static Balance Evaluation, Star Balance Test and Timed Get Up and Go Test for Dynamic Balance Assessment. The aim of this study is to investigate the effect of transcranial direct current stimulation applied on the supplementary motor area and cerebellum on static and dynamic balance in healthy individuals., conditionsModule conditions: Balance, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NON_RANDOMIZED, interventionModel: CROSSOVER, interventionModelDescription: All participants received 3 different interventions at different times., primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, maskingDescription: Participants were not informed which type of current was applied., whoMasked: PARTICIPANT, enrollmentInfo count: 30, type: ACTUAL, armsInterventionsModule interventions name: Transcranial Direct Current Stimulation, outcomesModule primaryOutcomes measure: Demographic Information Form, primaryOutcomes measure: Wii-Fit, primaryOutcomes measure: balance error scoring system, primaryOutcomes measure: star excursion balance test, primaryOutcomes measure: Time Up & Go Test, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 25 Years, stdAges: ADULT, contactsLocationsModule locations facility: Istanbul Medipol University, city: Istanbul, state: Beykoz, country: Turkey, geoPoint lat: 41.01384, lon: 28.94966, hasResults: False
protocolSection identificationModule nctId: NCT06383026, orgStudyIdInfo id: PRO00047199, briefTitle: Transgender and Gender-Diverse Breast Cancer Screening Pilot, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-04-17, primaryCompletionDateStruct date: 2027-12, completionDateStruct date: 2028-02, studyFirstPostDateStruct date: 2024-04-25, lastUpdatePostDateStruct date: 2024-04-25, sponsorCollaboratorsModule leadSponsor name: Medical College of Wisconsin, class: OTHER, descriptionModule briefSummary: This investigation is a prospective breast cancer screening study open to all transgender and gender-diverse persons (regardless of sex assigned at birth). Using a mixed methods approach, the study will 1) gather prospective quantitative breast imaging data in conjunction with gender-affirming therapy and family cancer history and 2) investigate TGD persons perceptions and experiences in the breast cancer screening program, and 3) identify individual and systems-level barriers to breast cancer screening., conditionsModule conditions: Breast Cancer, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 130, type: ESTIMATED, armsInterventionsModule interventions name: Breast Cancer Screening, interventions name: Survey/Interview, interventions name: Focus Group, outcomesModule primaryOutcomes measure: Callback and Biopsy Rates after Breast Cancer Screening, primaryOutcomes measure: Reflexive Thematic Analysis of the Physical, Cognitive, and Emotional Experience of Breast Cancer Screening in Transgender and Gender Diverse Persons, primaryOutcomes measure: Reflexive Thematic Analysis on the Individual & System-Level Barriers to Breast Cancer Screening, eligibilityModule sex: ALL, minimumAge: 30 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Medical College of Wisconsin, status: RECRUITING, city: Milwaukee, state: Wisconsin, zip: 53226, country: United States, contacts name: Chandler S Cortina, MD, MS, role: CONTACT, email: ccortina@mcw..edu, geoPoint lat: 43.0389, lon: -87.90647, hasResults: False
protocolSection identificationModule nctId: NCT06383013, orgStudyIdInfo id: BB-101-BBCBB1A, briefTitle: Phase II Study of BB-101 for the Treatment of Diabetic Lower Leg and Foot Ulcers, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-02-29, primaryCompletionDateStruct date: 2027-12-31, completionDateStruct date: 2028-12-31, studyFirstPostDateStruct date: 2024-04-25, lastUpdatePostDateStruct date: 2024-04-25, sponsorCollaboratorsModule leadSponsor name: Blue Blood Biotech Corp., class: INDUSTRY, descriptionModule briefSummary: This is a randomized, double-blinded, vehicle-controlled, parallel, phase II study to evaluate the efficacy and safety of topical BB-101 for the treatment of diabetic lower leg and foot ulcer., conditionsModule conditions: Diabetic Foot Ulcer, designModule studyType: INTERVENTIONAL, phases: PHASE2, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: QUADRUPLE, whoMasked: PARTICIPANT, whoMasked: CARE_PROVIDER, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 96, type: ESTIMATED, armsInterventionsModule interventions name: BB-101, outcomesModule primaryOutcomes measure: Efficacy Evaluation, secondaryOutcomes measure: Safety Evaluation, secondaryOutcomes measure: Secondary Efficacy Evaluation, otherOutcomes measure: Exploratory Objectives, eligibilityModule sex: ALL, minimumAge: 20 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare, status: RECRUITING, city: Taipei, country: Taiwan, contacts name: Shug-Cheng Chang, MD, role: CONTACT, geoPoint lat: 25.04776, lon: 121.53185, hasResults: False